Adagene Inc - ADR

-0.21 (-1.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)483.78M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11 Million
Adjusted EPS-$0.50
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Adagene Inc - ADR Stock, NASDAQ:ADAG

4/F, Building C14, Suzhou Industrial Park, Suzhou, Jiangsu 215123
Phone: +86.512.8777.3632
Number of Employees: 198


Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.